Aurora Commences Flowering of 2400 Medicinal Cannabis Plants Consisting of 7 Strains

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2015) - Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(WKN:A1C4WM)(OTC PINK:PSNTF) ("Aurora" or the "Company) is pleased to announce that 2400 clones of 7 different strains have been moved to the flowering stage. Commonly used names for the strains are Purple Kush, Agent Orange, Girl Scout Cookies, LSD, Strawberry Cough, AK47 and Exodus Cheese. Patients can be assured that the variety of strains will address a wide range of needs. More strains will be introduced as production ramps up. Aurora is expecting the first harvest to occur towards the end of June, 2015. Once in full production, the facility will be harvesting approximately 2500 plants every 7 days that will result in up to 100 kg of product per harvest.

Aurora's patient acquisition plan is in the process of being finalized and the Company is confident that it will establish a significant customer base for sales while ensuring that our patients are not compromised by product shortages. This is an exciting time for Aurora and its shareholders as Aurora will begin producing a steady stream of revenue through the sales of its expertly cultivated and safe artisanal medical cannabis to customers across Canada.

Inspectors of Health Canada's Office of Controlled Substances have visited Aurora twice since the cultivation license was issued (March 25 and April 21) and were satisfied with the facility, procedures and the progress thus far. The successful outcome of these and previous inspections continues to demonstrate Aurora's commitment to operating successfully in this developing branch of the pharmaceutical industry. Further, in keeping to its vision of producing artisanal medical-grade cannabis, Aurora is proceeding forward with production under a unique advisory relationship designed to expand and augment each strain's unique medical potential. This relationship was recently secured via an audit performed in California by Aurora's quality control team.

Aurora is pleased to announce that it has entered into a contract with Ample Organics to obtain, utilize, and be supported by their advanced seed to sale enterprise resource planning (ERP) software platform for cultivation and sales of medical cannabis and medical cannabis related products. The software will enhance Aurora's recordkeeping, traceability and overall efficiency in all aspects of facility operations. The progressive software will also help ensure that Aurora is operating as a leader in this expanding industry with only the most innovative solutions and products being made available to its future patients.

John Prentiss, CEO of Ample Organics, stated, "Ample Organics could not be more excited to have the privilege of working with the talented and experienced team at Aurora. Their purpose-built, state- of-the-art facility will now be powered by the most comprehensive software solution available today. We firmly believe that this partnership will set the bar thus further defining the Aurora Standard as the leader in this nascent industry, resulting in the best client experience in the cannabis space at every level."

Aurora has also entered into a contract to employ the services of MMJ Hype, a division of Triforce Media Inc., a full service cannabis-marketing agency that is dedicated to providing Aurora with the highest quality search engine optimization (SEO), social media, marketing, reputation management and web analytics in the industry. Maxwell Duchaine commented, "MMJ Hype is looking forward to working with Aurora on generating additional website traffic from search engines and increasing brand awareness across Canada. MMJ Hype and Triforce Media will leverage the latest digital marketing tactics to ensure a leading position within this burgeoning industry."

Aurora has entered into 11 non-disclosure agreements including 4 in the United States to review in detail additional synergistic opportunities within the cannabis space. Terry Booth, CEO of Aurora, commented: "The opportunities in the Cannabis industry are plentiful. It is imperative that we stay on point and focus on our strategy which is inherent to our strengths and talents."

Aurora is the gold sponsor of the upcoming Jacob Securities Inc. investment event. Jacob Securities is a Toronto based, independent full-service investment bank, providing underwriting and financial advisory services to companies in the power, infrastructure, technology, energy and mining sectors. The event has attracted investors from around the world. Leslie Bocskor of Electrum Partners and Terry Booth, CEO of Aurora, will be guest speakers at the event.

In addition to the Jacobs investor conference, Aurora is proud to be a part of the upcoming Canadian Securities Exchange event hosted on May 6^th in Calgary. The "TakeStock! Alberta Spring Investor Forum" will be featuring Aurora's CEO, Terry Booth, as a speaker.

With regard to the Bakerview Business Borough in Bellingham, Washington, the Company's wholly- owned subsidiary, Australis Capital Inc., is pleased to announce that this project has progressed with the signing of a Memorandum of Understanding with AJR Builders Group. This signing is another step towards developing Australis Holdings LLP's plans in the creation of the best multifaceted project in Washington State that will exclusively cater to the recreational and medical cannabis industry.

About Aurora Cannabis Inc.

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada. Aurora's wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market. Our consultant, Electrum Partners, LLP, in Nevada, our partner, AJR Builders Group, LLC, in Washington State and our 50% owned subsidiary, Australis Holdings LLP, are the first key steps in executing our growth strategy south of the Canadian border. Aurora is trading on the Canadian Securities Exchange under the trading symbol "ACB".

On behalf of the Board of Directors, AURORA CANNABIS INC.

Terry Booth, CEO

This news release contains statements about the Company's expectations regarding anticipated production yields, product demand and Aurora's ability to meet that demand, expansion and development plans and other aspects of its anticipated future operations that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward- looking statements. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Such factors include but are not limited to the Company's ability to raise sufficient capital and the general impact of financial market conditions, the yield from marijuana growing operations, product demand, changes in prices of required commodities, market and customer interest of the Company's products and services, competition, government regulations, litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which the Company operate and other risks set out in the Company's management's discussion and analysis filed on SEDAR. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.